search
Back to results

Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients

Primary Purpose

Kidney Transplantation

Status
Unknown status
Phase
Locations
Italy
Study Type
Observational
Intervention
Sponsored by
IRCCS Policlinico S. Matteo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Kidney Transplantation focused on measuring kidney, transplant, Mycophenolic acid, Inosine monophosphate dehydrogenase

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Renal transplant recipients
  • Age range: 18-70
  • Patients taking MMF
  • Able to understand and sign an informed consent

Exclusion Criteria:

  • Active myelodepression
  • Systemic infections or other that may affect MMF absorption
  • Pregnancy/breastfeeding
  • (History of) cancer
  • Drug abuse, psychiatric conditions
  • Already enrolled in other clinical trials or participation ended less than one month earlier
  • Known sensitivity to polysorbate 80 or MMF

Sites / Locations

  • IRCCS Fondazione Policlinico San Matteo

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Arm Label

1

2

3

Arm Description

MMF+cyclosporine

MMF+tacrolimus

MMF+sirolimus

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
October 24, 2008
Last Updated
October 24, 2008
Sponsor
IRCCS Policlinico S. Matteo
search

1. Study Identification

Unique Protocol Identification Number
NCT00780429
Brief Title
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
Official Title
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months
Study Type
Observational

2. Study Status

Record Verification Date
October 2008
Overall Recruitment Status
Unknown status
Study Start Date
June 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
IRCCS Policlinico S. Matteo

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy). Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Transplantation
Keywords
kidney, transplant, Mycophenolic acid, Inosine monophosphate dehydrogenase

7. Study Design

Enrollment
54 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Description
MMF+cyclosporine
Arm Title
2
Arm Description
MMF+tacrolimus
Arm Title
3
Arm Description
MMF+sirolimus

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Renal transplant recipients Age range: 18-70 Patients taking MMF Able to understand and sign an informed consent Exclusion Criteria: Active myelodepression Systemic infections or other that may affect MMF absorption Pregnancy/breastfeeding (History of) cancer Drug abuse, psychiatric conditions Already enrolled in other clinical trials or participation ended less than one month earlier Known sensitivity to polysorbate 80 or MMF
Study Population Description
Male and female renal transplant patients
Sampling Method
Non-Probability Sample
Facility Information:
Facility Name
IRCCS Fondazione Policlinico San Matteo
City
Pavia
ZIP/Postal Code
27100
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients

We'll reach out to this number within 24 hrs